Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Clinical trial NCT01304797 · UNKNOWN
Trial details
- NCT number
- NCT01304797
- Sponsor
- Merrimack Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2016-08-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.